Iron Overload and Bone Disease in Chronic Dialysis Patients

2015 ◽  
pp. 134-143 ◽  
Author(s):  
Frank L. Van de Vyver ◽  
Walter J. Visser ◽  
Patrick C. D�Haese ◽  
Marc E. De Broe
Keyword(s):  
Iron Overload ◽  
Bone Disease ◽  
Chronic Dialysis ◽  
Dialysis Patients

Iron Overload and Bone Disease in Chronic Dialysis Patients

1990 ◽  
Vol 5 (9) ◽  
pp. 781-787 ◽  
Author(s):  
F. L. van de Vyver ◽  
W. J. Visser ◽  
P. C. D'Haese ◽  
M. E. de Broe
Keyword(s):  
Iron Overload ◽  
Bone Disease ◽  
Chronic Dialysis ◽  
Dialysis Patients

Correlation Between Recombinant Human Erythropoietin Dose and Inflammatory Status in Dialysed Patients

2017 ◽  
Vol 68 (2) ◽  
pp. 354-357 ◽  
Author(s):  
Andrei Niculae ◽  
Cristiana David ◽  
Razvan Florin Ion Dragomirescu ◽  
Ileana Peride ◽  
Flavia Liliana Turcu ◽  
...  
Keyword(s):  
Adverse Effects ◽  
Recombinant Human Erythropoietin ◽  
Best Practice ◽  
Daily Practice ◽  
Therapeutic Benefit ◽  
Chronic Dialysis ◽  
Dialysis Patients ◽  
Protein Levels ◽  
Human Erythropoietin ◽  
Inflammatory Status

Once recombinant human erythropoietin (r-HuEPO) was introduced in daily practice, huge steps were made in combating the adverse effects induced by anemia in chronic kidney disease population. Still, r-HuEPO resistance and the doses ensuring the maximum therapeutic benefit remain matters of debate. The aim of our study was to assess the correlation between the presence and the degree of inflammation and the r-HuEPO requirements in chronic dialysis patients. We conducted a 2 years prospective study on 146 patients undergoing chronic dialysis treated with r-HuEPO. Based on their average CRP (C-reactive protein) levels, obtained from repeated samplings at 3 months interval, 3 groups were formed; we noted in each group the average values of r-HuEPO prescribed to achieve the optimum hemoglobin levels according to the dialysis best practice guidelines and all the adverse effects of the therapy. A direct correlation was observed between CRP levels and r-HuEPO requirements in the first 2 groups of patients (CRP under 6 mg/L and CRP values 6-20 mg/L), with significant increase in r-HuEPO doses between groups (p [ 0.001); the third group, CRP values over 20 mg/dL, showed a minor, insignificant increase in average r-HuEPO doses compared to mild inflammation group (p = 0.199) and more adverse effects of the therapy (p [ 0.05). Inflammation is an important determinant of anemia in chronic dialysis patients and can induce an increase in the doses of r-HuEPO. However, prescribing excessive r-HuEPO doses is not the answer in severe inflammatory status, due to lack of response and possible adverse effects.

scholarly journals SP400EFFECT OF CHOLECALCIFEROL SUPPLEMENTATION ON TLR7, TLR9, IL-6 AND IFN-Y EXPRESSION IN B AND T LYMPHOCYTES ON CHRONIC DIALYSIS PATIENTS

2015 ◽  
Vol 30 (suppl_3) ◽  
pp. iii511-iii511
Author(s):  
Jose Tarcisio Giffoni de Carvalho ◽  
Marion Schneider ◽  
Lilian Cuppari ◽  
Caren Cristina Grabulosa ◽  
Silvia Regina Manfredi ◽  
...  
Keyword(s):  
T Lymphocytes ◽  
Chronic Dialysis ◽  
Dialysis Patients ◽  
Cholecalciferol Supplementation ◽  
B And T Lymphocytes

scholarly journals POS-543 EXPERIENCE OF COVID 19 DISEASE ON 159 ECUADORIAN CHRONIC DIALYSIS PATIENTS

2021 ◽  
Vol 6 (4) ◽  
pp. S237
Author(s):  
J. SANTACRUZ ◽  
C. Santacruz Tipanta ◽  
A. Vasquez Pérez ◽  
P. Reinoso ◽  
S. Carlotta ◽  
...  
Keyword(s):  
Chronic Dialysis ◽  
Dialysis Patients

Risk of death among chronic dialysis patients infected with hepatitis C virus

1998 ◽  
Vol 32 (4) ◽  
pp. 629-634 ◽  
Author(s):  
CO Stehman-Breen ◽  
S Emerson ◽  
D Gretch ◽  
RJ Johnson
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Chronic Dialysis ◽  
Dialysis Patients ◽  
Risk Of Death

URINARY CALCULI IN CHRONIC DIALYSIS PATIENTS

The Lancet ◽  
1979 ◽  
Vol 314 (8150) ◽  
pp. 1024-1025 ◽  
Author(s):  
A. Caralps ◽  
J. Lloveras ◽  
J. Andreu ◽  
A. Brulles ◽  
J. Masramon ◽  
...  
Keyword(s):  
Urinary Calculi ◽  
Chronic Dialysis ◽  
Dialysis Patients

scholarly journals Increased risk of cancer in chronic dialysis patients: a population-based cohort study in Taiwan

2011 ◽  
Vol 27 (4) ◽  
pp. 1585-1590 ◽  
Author(s):  
H.-F. Lin ◽  
Y.-H. Li ◽  
C.-H. Wang ◽  
C.-L. Chou ◽  
D.-J. Kuo ◽  
...  
Keyword(s):  
Cohort Study ◽  
Population Based ◽  
Chronic Dialysis ◽  
Dialysis Patients ◽  
Increased Risk ◽  
Risk Of Cancer

What are the Consequences of Volume Expansion in Chronic Dialysis Patients?

2015 ◽  
Vol 28 (3) ◽  
pp. 235-239 ◽  
Author(s):  
Mohamed E. Elsayed ◽  
Austin G. Stack
Keyword(s):  
Volume Expansion ◽  
Chronic Dialysis ◽  
Dialysis Patients

scholarly journals Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients

1999 ◽  
Vol 14 (8) ◽  
pp. 1956-1960 ◽  
Author(s):  
Kunitoshi Iseki ◽  
Masahiko Tozawa ◽  
Shinichiro Yoshi ◽  
Koshiro Fukiyama
Keyword(s):  
Chronic Dialysis ◽  
C Reactive Protein ◽  
Dialysis Patients ◽  
Reactive Protein ◽  
Risk Of Death
Sign in / Sign up

Export Citation Format

Share Document